Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gut microbiota refers to the diverse community of microorganisms that inhabit the digestive tracts of animals, particularly humans. It plays a crucial role in fermentation, vitamin synthesis, immune system modulation, and maintaining gut barrier integrity. Its composition is influenced by diet, antibiotics, age, and genetics. Alterations in the gut microbiota (dysbiosis) are associated with various diseases, including obesity, inflammatory bowel disease, metabolic syndrome, and cancer.
Antibiotics: Disrupt bacterial cell wall or inhibit bacterial protein synthesis. Prebiotics: Promote growth of beneficial bacteria by providing substrates. Probiotics: Introduce beneficial bacteria to the gut. FMT: Replenish depleted microbial diversity and restore gut homeostasis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut Microbiota (None).